William Blair Has Negative Estimate for USPH Q1 Earnings

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at William Blair dropped their Q1 2025 earnings per share estimates for shares of U.S. Physical Therapy in a research note issued to investors on Thursday, February 27th. William Blair analyst J. Haase now expects that the company will post earnings per share of $0.56 for the quarter, down from their prior forecast of $0.59. William Blair currently has a “Market Perform” rating on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. William Blair also issued estimates for U.S. Physical Therapy’s Q1 2025 earnings at $0.56 EPS, Q2 2025 earnings at $0.79 EPS, Q2 2025 earnings at $0.79 EPS, Q4 2025 earnings at $0.78 EPS, Q4 2025 earnings at $0.78 EPS, FY2025 earnings at $2.96 EPS and FY2025 earnings at $2.96 EPS.

A number of other analysts have also issued reports on the company. Barrington Research restated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. JPMorgan Chase & Co. raised their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their target price for the company from $100.00 to $115.00 in a report on Monday, December 16th. Finally, JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price target for the company. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $114.00.

U.S. Physical Therapy Trading Down 6.2 %

U.S. Physical Therapy stock opened at $82.25 on Friday. U.S. Physical Therapy has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 87.50, a P/E/G ratio of 3.54 and a beta of 1.48. The company has a 50 day moving average price of $88.41 and a 200 day moving average price of $87.67.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The firm had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Insider Activity at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of USPH. CBIZ Investment Advisory Services LLC lifted its stake in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter worth about $39,000. Venturi Wealth Management LLC boosted its stake in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock worth $64,000 after acquiring an additional 704 shares in the last quarter. KBC Group NV boosted its stake in shares of U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company’s stock worth $66,000 after acquiring an additional 315 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the 4th quarter valued at about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.